Showing results (11-20 of 266) with videos related to
Sort By:
Pageof 27
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2014
Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cellsCarolina Petrillo, Daniela Cesana, Francesco Piras, et al.Journal of Virology|February 15, 2013
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradationAndrea Di Pietro, Anna Kajaste-Rudnitski, Alexandra Oteiza, et al.Human Gene Therapy|September 6, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral VectorsHelena Costa-Verdera, Carmen Unzu, Erika Valeri, et al.La Medicina Del Lavoro|July 31, 2012
Assessment of efficacy and safety of pandemic A/H1N1/2009 influenza vaccine in a group of health care workersP Mascagni, Elisa Vicenzi, Anna Kajaste-Rudnitski, et al.Current Opinion in Molecular Therapeutics|November 19, 2002
Advances in gene therapy for ADA-deficient SCIDAlessandro AiutiBest Practice & Research. Clinical Haematology|October 23, 2004
Gene therapy for adenosine-deaminase-deficient severe combined immunodeficiencyAlessandro AiutiThe Journal of Experimental Medicine|July 2, 2024
A novel STING variant triggers endothelial toxicity and SAVI diseaseErika Valeri, Sara Breggion, Federica Barzaghi, et al.The Journal of Gene Medicine|March 15, 2008
A dimerizable cationic lipid with potential for gene deliveryGabriele Candiani, Daniele Pezzoli, Mariasara Cabras, et al.Virology|January 27, 2010
Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1bEva Mertens, Anna Kajaste-Rudnitski, Shessy Torres, et al.Retrovirology|December 20, 2015
HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoterFilippo Turrini, Sara Marelli, Anna Kajaste-Rudnitski, et al.Pageof 27